Orion Pharma (DHA:ORIONPHARM) Cyclically Adjusted Book per Share: BDT95.81 (As of Mar. 2026)


DHA:ORIONPHARM Orion Pharma Ltd DHA:ORIONPHARM
71 GF Score
Price BDT30.70
GF Value BDT20.19
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Orion Pharma Cyclically Adjusted Book per Share?

Orion Pharma DHA:ORIONPHARM +3.02% 71 Cyclically Adjusted Book per Share is BDT95.81 as of Mar. 2026. GuruFocus rates DHA:ORIONPHARM with a GF Score™ of 71/100 and a GF Value™ of BDT20.19 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Orion Pharma's adjusted book value per share for the three months ended in Mar. 2026 was BDT85.461. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is BDT95.81 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Orion Pharma's average Cyclically Adjusted Book Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-12), Orion Pharma's current stock price is BDT30.70. Orion Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was BDT95.81. Orion Pharma's Cyclically Adjusted PB Ratio of today is 0.32.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Orion Pharma was 0.95. The lowest was 0.26. And the median was 0.40.


Orion Pharma  (DHA:ORIONPHARM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Orion Pharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=30.70/95.81
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Orion Pharma was 0.95. The lowest was 0.26. And the median was 0.40.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Orion Pharma Cyclically Adjusted Book per Share Related Terms


Orion Pharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Orion Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Pharma Cyclically Adjusted Book per Share Chart

Orion Pharma Annual Data
Trend Dec14 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 88.59 91.74 94.12

Orion Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.45 94.12 94.68 94.25 95.81

DHA:ORIONPHARM vs CEG, VST, NRG: Cyclically Adjusted Book per Share Comparison

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma Cyclically Adjusted PB Ratio vs Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Cyclically Adjusted PB Ratio falls into.


DHA:ORIONPHARM
71GF Score
Orion Pharma Ltd DHA:ORIONPHARM
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orion Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orion Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=85.461/330.2130*330.2130
=85.461

Current CPI (Mar. 2026) = 330.2130.

Orion Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201509 69.475 237.945 96.415
201609 71.088 241.428 97.231
201612 70.717 241.432 96.722
201703 71.142 243.801 96.357
201706 70.951 244.955 95.646
201709 72.054 246.819 96.399
201712 71.460 246.524 95.719
201803 72.074 249.554 95.369
201806 72.881 251.989 95.505
201809 73.650 252.439 96.341
201812 73.324 251.233 96.375
201903 74.292 254.202 96.507
201906 75.190 256.143 96.933
201909 76.326 256.759 98.161
201912 75.728 256.974 97.311
202003 76.685 258.115 98.105
202006 76.768 257.797 98.332
202009 77.811 260.280 98.718
202012 77.908 260.474 98.767
202103 78.782 264.877 98.215
202106 79.755 271.696 96.932
202109 80.548 274.310 96.963
202112 80.937 278.802 95.862
202203 81.965 287.504 94.141
202206 82.532 296.311 91.975
202209 92.649 296.808 103.076
202212 91.747 296.797 102.077
202303 87.373 301.836 95.587
202306 88.993 305.109 96.315
202309 89.653 307.789 96.185
202312 89.686 306.746 96.547
202403 93.011 312.332 98.336
202406 92.049 314.175 96.748
202409 89.882 315.301 94.133
202412 89.821 315.605 93.978
202503 89.179 319.799 92.083
202506 86.093 322.561 88.135
202509 89.865 324.800 91.363
202512 85.742 324.054 87.372
202603 85.461 330.213 85.461

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of BDT95.81 mean?
Orion Pharma (DHA:ORIONPHARM) has a Cyclically Adjusted Book per Share of BDT95.81 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Orion Pharma and its competitors.
Is Orion Pharma's Cyclically Adjusted Book per Share too high?
Orion Pharma's current Cyclically Adjusted Book per Share is BDT95.81. Overall, Orion Pharma has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Orion Pharma's Cyclically Adjusted Book per Share compare to CEG and VST?
Orion Pharma's Cyclically Adjusted Book per Share of BDT95.81 can be compared against companies in the Utilities - Independent Power Producers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for an Utilities - Independent Power Producers company?
A good Cyclically Adjusted Book per Share depends on the Utilities - Independent Power Producers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Orion Pharma and its competitors. Orion Pharma's current Cyclically Adjusted Book per Share is BDT95.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Pharma stock overvalued right now?
Based on GuruFocus' analysis, Orion Pharma (DHA:ORIONPHARM) is currently considered Significantly Overvalued. The stock's GF Value™ is BDT20.19, compared to a current price of BDT30.70 — trading 52.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is BDT95.81. Orion Pharma's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Orion Pharma (DHA:ORIONPHARM), the current Cyclically Adjusted Book per Share is BDT95.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orion Pharma (DHA:ORIONPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Pharma stock appears to be overvalued. The current stock price of BDT30.70 is trading 52.1% above its estimated GF Value™ of BDT20.19. GuruFocus considers Orion Pharma to be Significantly Overvalued.

Key valuation signals for DHA:ORIONPHARM:

  • Cyclically Adjusted Book per Share: BDT95.81
  • GF Value™: BDT20.19 vs. price of BDT30.70 (52.1% above fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the DHA:ORIONPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Orion Pharma Business Description

Address 153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. The company produces diversified dosage forms such as tablets, capsules, syrups, solutions, suspensions, powder for suspensions, creams, ointments, and injections under therapeutic categories including cardiovascular, antiulcerant, antiasthmatic, antihistamine, NSAIDs, antibiotic, antifungal, laxatives, anticancer, vitamins, and minerals. In addition, the company is involved in power generation activities and generates maximum revenue from pharmaceutical activities. The group principally carries out its business operations and markets its products in Bangladesh.
71GF Score

Get the complete analysis for DHA:ORIONPHARM

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT30.70
Price
BDT20.19
GF Value